Fig. 6From: Activated TAZ induces liver cancer in collaboration with EGFR/HER2 signaling pathwaysHistological analyses of tumors induced by TAZS89A plus BRAFV600E and TAZS89A plus PI3KE545K. H&E and IHC staining images of liver sections expressing indicated oncogenes. Scale bar, 50 μmBack to article page